BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9838087)

  • 1. The role of PI 3-kinase in insulin action.
    Alessi DR; Downes CP
    Biochim Biophys Acta; 1998 Dec; 1436(1-2):151-64. PubMed ID: 9838087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nelfinavir-induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt/PKB and PKC-zeta.
    Ben-Romano R; Rudich A; Tirosh A; Potashnik R; Sasaoka T; Riesenberg K; Schlaeffer F; Bashan N
    Diabetologia; 2004 Jun; 47(6):1107-17. PubMed ID: 15168016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor-alpha activation of protein kinase B in WEHI-164 cells is accompanied by increased phosphorylation of Ser473, but not Thr308.
    O'toole A; Moule SK; Lockyer PJ; Halestrap AP
    Biochem J; 2001 Oct; 359(Pt 1):119-27. PubMed ID: 11563975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of activation and function of protein kinase B.
    Alessi DR; Cohen P
    Curr Opin Genet Dev; 1998 Feb; 8(1):55-62. PubMed ID: 9529606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphoinositide 3-kinase pathway.
    Cantley LC
    Science; 2002 May; 296(5573):1655-7. PubMed ID: 12040186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation.
    Carricaburu V; Lamia KA; Lo E; Favereaux L; Payrastre B; Cantley LC; Rameh LE
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9867-72. PubMed ID: 12897244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase.
    Andjelković M; Maira SM; Cron P; Parker PJ; Hemmings BA
    Mol Cell Biol; 1999 Jul; 19(7):5061-72. PubMed ID: 10373555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
    Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB
    Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.
    Alessi DR; James SR; Downes CP; Holmes AB; Gaffney PR; Reese CB; Cohen P
    Curr Biol; 1997 Apr; 7(4):261-9. PubMed ID: 9094314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PtdIns(3,4,5)P3 gets its message across.
    Hemmings BA
    Science; 1997 Jul; 277(5325):534. PubMed ID: 9254423
    [No Abstract]   [Full Text] [Related]  

  • 11. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
    Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase--significance for diabetes and cancer.
    Galetic I; Andjelkovic M; Meier R; Brodbeck D; Park J; Hemmings BA
    Pharmacol Ther; 1999; 82(2-3):409-25. PubMed ID: 10454216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B.
    Stephens L; Anderson K; Stokoe D; Erdjument-Bromage H; Painter GF; Holmes AB; Gaffney PR; Reese CB; McCormick F; Tempst P; Coadwell J; Hawkins PT
    Science; 1998 Jan; 279(5351):710-4. PubMed ID: 9445477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction.
    Cohen P
    Philos Trans R Soc Lond B Biol Sci; 1999 Feb; 354(1382):485-95. PubMed ID: 10212493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraction inhibits insulin-stimulated insulin receptor substrate-1/2-associated phosphoinositide 3-kinase activity, but not protein kinase B activation or glucose uptake, in rat muscle.
    Whitehead JP; Soos MA; Aslesen R; O'rahilly S; Jensen J
    Biochem J; 2000 Aug; 349 Pt 3(Pt 3):775-81. PubMed ID: 10903138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism.
    Powell DJ; Hajduch E; Kular G; Hundal HS
    Mol Cell Biol; 2003 Nov; 23(21):7794-808. PubMed ID: 14560023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B.
    Stratford S; Hoehn KL; Liu F; Summers SA
    J Biol Chem; 2004 Aug; 279(35):36608-15. PubMed ID: 15220355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of protein kinase B.
    Meier R; Hemmings BA
    J Recept Signal Transduct Res; 1999; 19(1-4):121-8. PubMed ID: 10071752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A target for phosphoinositide 3-kinase: Akt/PKB.
    Bos JL
    Trends Biochem Sci; 1995 Nov; 20(11):441-2. PubMed ID: 8578585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.